Adma Biologicsincis A Biopharmaceutical Company Based In Theu Sthat Specializes In Plasma Derived Therapeutics For Immunecompromised Patients And Infectious Diseasepreventionfounded In 2004Adma Operates As A Fully Integrated Entitymanaging Plasma Collectionmanufacturingand Distributionthecompany Has 10 Plasma Collection Centers And A Significant Annual Plasma Fractionation Capacity Adma Markets Threefda Approved Therapiesbivigama A Polyvalent Intravenous Immunoglobulin For Primary Humoral Immunodeficiencyasceniva Can Ivig Product For Both Adults And Childrenand Nabi Hba Which Provides Post Exposureprophylaxis Against Hepatitis Badditionallyadma Offers Contract Manufacturing Servicesincluding Aseptic Filling And Gmp Testingand Utilizes Proprietary Technology To Enhanceproduct Efficacythecompany Serves Hospitalsspecialty Pharmaciesand Healthcareprovidersfocusing On Critical Needs In Immunedeficiency And Hepatitis B Prevention
